Health technology assessment

Short description: Field of policy analysis

For the journal, see Health Technology Assessment (journal).

Script error: No such module "other uses of".

HTA conference and workshop

Health technology assessment (HTA) is a multidisciplinary process that uses systematic and explicit methods to evaluate the properties and effects of a health technology.[1] Health technology is conceived as any intervention (test, device, medicine, vaccine, procedure, program) at any point in its lifecycle (pre-market, regulatory approval, post-market, disinvestment).[2] The purpose of HTA is to inform "decision-making in order to promote an equitable, efficient, and high-quality health system".[3] It has other definitions including "a method of evidence synthesis that considers evidence regarding clinical effectiveness, safety, cost-effectiveness and, when broadly applied, includes social, ethical, and legal aspects of the use of health technologies. The precise balance of these inputs depends on the purpose of each individual HTA. A major use of HTAs is in informing reimbursement and coverage decisions by insurers and national health systems, in which case HTAs should include benefit-harm assessment and economic evaluation."[4] And "a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value. Despite its policy goals, HTA must always be firmly rooted in research and the scientific method".[5]

## Contents

* 1 Purpose
* 2 History
* 3 By country
* 3.1 United Kingdom
* 3.2 Canada
* 3.3 Italy
* 3.4 Germany
* 4 Impact of HTA implementation
* 5 See also
* 6 References
* 7 External links

## Purpose

Health technology assessment is intended to provide a bridge between the world of research and the world of decision-making.[6] HTA is an active field internationally and has seen continued growth fostered by the need to support management, clinical, and policy decisions. It has also been advanced by the evolution of evaluative methods in the social and applied sciences, including clinical epidemiology and health economics. Health policy decisions are becoming increasingly important as the opportunity costs from making wrong decisions continue to grow.[7] HTA is now also used in assessment of innovative medical technologies like telemedicine e.g. by use of the Model for assessment of telemedicine (MAST).

Health technology can be defined broadly as:

> Any intervention that may be used to promote health, to prevent, diagnose or treat disease or for rehabilitation or long-term care. This includes the pharmaceuticals, devices, procedures and organizational systems used in health care.[8]

## History

The discipline of HTA was first developed in the U.S. Office of Technology Assessment, which published its first report in 1976.[9] The growth of HTA internationally can be seen in the expanding membership of the International Network of Agencies for Health Technology Assessment (INAHTA), a non-profit umbrella organization established in 1993.[10] Organizations and individuals involved in the production of HTA publications may also affiliated with international societies such as Health Technology Assessment International (HTAi)[11] and International Society for Pharmacoeconomics and Outcomes Research (ISPOR).[12] Academic courses, typically in Masters programs, are also offered in health technology assessment and management.[13][14]

## By country

The World Health Organization provides an overview of countries and their corresponding HTA agencies.[15]

### United Kingdom

The United Kingdom's National Institute for Health and Care Research (NIHR) runs several research programmes that may be viewed as falling into the realm of Health Technology Assessment. Of particular note is the NIHR Health Technology Assessment programme, its longest running, which undertakes both conventional HTA in the form of Evidence Synthesis and modelling, and evidence generation with a large portfolio of pragmatic RCTs and cohort studies.[16] The programme's research is regularly published in NIHR's journal Health Technology Assessment.[17]

Also in the UK, the Multidisciplinary Assessment of Technology Centre for Healthcare carries out HTA in collaboration with the health service, the NHS and various industrial partners. MATCH is organised into four themes addressing key HTA topics including Health Economics, Tools for Industry, User Needs and Procurement and Supply chain.

### Canada

Canada also has a health technology assessment body called Canada's Drug Agency,[18] formerly called the Canadian Agency for Drugs and Technologies in Health (CADTH).[19]

### Italy

As of today, 11 Italian regions have issued specific regional laws or regulations to manage HTA activities and processes at regional level: Abruzzo, Basilicata, Emilia-Romagna, Lazio, Liguria, Lombardia, Piemonte, Puglia, Sicilia, Toscana, and Veneto. In another four regions (Calabria, Marche, Umbria, and Valle D'Aosta) and in the two autonomous provinces of Bolzano and Trento, HTA is performed at different levels, even if no legislation has yet been produced.[20]

### Germany

In Germany, Health Technology Assessment is overseen by the Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA), the highest decision-making body of the joint self-government of physicians, hospitals and health insurance funds.

The G-BA decides on the benefits package of the statutory health insurance system. As part of this role, it conducts benefit assessments of new medical interventions. The Institute for Quality and Efficiency in Health Care (IQWiG) provides scientific evaluations and reports that inform the G-BA's decisions.[21]

## Impact of HTA implementation

This section may lend undue weight to certain ideas, incidents, or controversies. Please help to create a more balanced presentation. Discuss and resolve this issue before removing this message. (February 2024)

|

A recent study[22] explored the implementation of HTA in three middle-income countries (MICs) and its influence on health system objectives. The study investigated the impact of HTA globally through a systematic literature review. The study also surveyed stakeholders from the middle-income countries.

The results indicated that the benefits of HTA implementation in these countries largely outweigh the drawbacks. The major advantages identified include enhanced transparency and accountability in healthcare decisions, leading to more informed and equitable healthcare policies.

The study has shown that HTA has a positive impact on several aspects of healthcare systems:

* Improved decision making: HTA aids in making better health financing decisions, including resource allocation and policy formulation.
* Enhanced transparency and accountability: The most evident benefit of HTA is its role in improving the clarity and responsibility of healthcare decisions.
* Economic impact: While HTA can generate cost savings in specific areas, its overall impact on the fiscal sustainability of healthcare systems in MICs remains unclear.

It was also noted that HTA's influence extends to the broader health system goals, such as health gain, equity in health, and responsiveness to patient needs. However, the impact on direct health gains and financial protection of households is less pronounced.

The study emphasizes the gradual adoption of HTA in MICs and the necessity for continuous assessment of its impact.

## See also

* Horizon scanning
* Pharmacoeconomics

## References

1. ↑ O'Rourke, Brian; Oortwijn, Wija; Schuller, Tara (June 2020). "The new definition of health technology assessment: A milestone in international collaboration" (in en). International Journal of Technology Assessment in Health Care 36 (3): 187–190. doi:10.1017/S0266462320000215. ISSN 0266-4623. PMID 32398176.
2. ↑ "The International Network of Agencies for Health Technology Assessment" (in en-US). https://www.inahta.org/.
3. ↑ "The International Network of Agencies for Health Technology Assessment" (in en-US). https://www.inahta.org/.
4. ↑ ". EBM, HTA, and CER: clearing the confusion". Milbank Q 88 (2): 256–76. 2010. doi:10.1111/j.1468-0009.2010.00598.x. PMID 20579285.
5. ↑ EUnetHTA (European network for Health Technology Assessment) https://www.eunethta.eu/about-eunethta/
6. ↑ Battista, RN: The scientific basis of health services. BMJ Publishing Group, 1996.
7. ↑ Menon D.; Marshall, D (1996). "The internationalization of heath technology assessment". International Journal of Technology Assessment in Health Care 12 (1): 45–51. doi:10.1017/S0266462300009375. PMID 8690561.
8. ↑ INAHTA (International Network of Agencies for Health Technology Assessment). (Oct 8, 2013). "HTA glossary.". HTAi. http://htaglossary.net/tiki-index.php?page=health technology.
9. ↑ O'Rourke, Brian; Oortwijn, Wija; Schuller, Tara; the International Joint Task Group (13 May 2020). "The new definition of health technology assessment: A milestone in international collaboration" (in en). International Journal of Technology Assessment in Health Care 36 (3): 187–190. doi:10.1017/S0266462320000215. ISSN 0266-4623. PMID 32398176.
10. ↑ "The History of INAHTA". International Network of Agencies for Health Technology Assessment (INAHTA). https://www.inahta.org/about-inahta/history/.
11. ↑ "Health Technology Assessment International (HTAi)" (in en-US). https://htai.org/.
12. ↑ "International Society for Pharmacoeconomics and Outcomes Research". https://www.ispor.org/.
13. ↑ Lehoux, Pascale; Battista, Renaldo N.; Granados, Alicia; Gallo, Pedro; Tailliez, Stéphanie; Coyle, Doug; Marchetti, Marco; Borgia, Piero et al. (2005). "International Master's Program in health technology assessment and management: assessment of the first edition (2001--2003)". International Journal of Technology Assessment in Health Care 21 (1): 104–112. doi:10.1017/s0266462305050130. ISSN 0266-4623. PMID 15736521.
14. ↑ "A Tale of Two University-Based Health Technology Assessment Initiatives". https://www.cadth.ca/media/symposium_pdfs/cadth_symposium06_poster_BaPham.pdf.
15. ↑ "Countries with National agency/unit/committee that produces HTA reports for the Ministry of Health". 2021-04-08. https://cdn.who.int/media/docs/default-source/health-economics/nationalagenciehta.pdf.
16. ↑ "Health Technology Assessment". https://www.nihr.ac.uk/explore-nihr/funding-programmes/health-technology-assessment.htm.
17. ↑ "About the HTA journal". https://www.journalslibrary.nihr.ac.uk/hta/about-the-hta-journal.htm.
18. ↑ "Canada's Drug Agency". https://www.cda-amc.ca/.
19. ↑ "CADTH | CADTH". https://www.cadth.ca/.
20. ↑ "HTA in Italy: results from the national survey by Agenas and SIHTA. Read English summary produced by MTRC" (in en). 27 July 2017. https://mtrconsult.com/news/hta-italy-results-national-survey-agenas-and-sihta-read-english-summary-produced-mtrc.
21. ↑ "Benefit Assessment of Medicinal Products | G-BA" (in en). https://www.g-ba.de/english/benefitassessment/.
22. ↑ Fasseeh, Ahmad Nader; Saragih, Sarah Maria; Hayek, Noha; Brodovska, Sasha; Ismail, Adham; ElShalakani, Amr; Abaza, Sherif; Obeng, George Dennis et al. (2022-12-01). "Impact of health technology assessment implementation with a special focus on middle-income countries". Health Policy and Technology 11 (4). doi:10.1016/j.hlpt.2022.100688. ISSN 2211-8837. https://www.sciencedirect.com/science/article/pii/S2211883722000958.

## External links

* Health Technology Assessment International (HTAi)
* International Network of Agencies for Health Technology Assessment (INAHTA)
* European Network for Health Technology Assessment (EUnetHTA)

* v
* t
* e

Evidence-based practice

Key terms|

* Evidence-based practice
* Hierarchy of evidence

Applications|

* Effective altruism
* Evidence-based assessment
* Evidence-based conservation
* Evidence-based dentistry
* Evidence-based design
* Evidence-based education
* Evidence-based legislation
* Evidence-based library and information practice
* Evidence-based management
* Evidence-based medical ethics
* Evidence-based medicine
* Evidence-based nursing
* Evidence-based pharmacy in developing countries
* Evidence-based policing
* Evidence-based policy
* Evidence-based scheduling
* Evidence-based toxicology
* Journalology
* Metascience

Methods and concepts|

* Clinical trial
* Systematic review
* Meta-analysis
* Randomized controlled trial
* Health technology assessment
* PICO process
* GRADE
* Pragmatic clinical trial
* Risk assessment
* Scientific uncertainty
* Policy-based evidence making

People|

* Iain Chalmers
* Ken Harvey
* John Ioannidis

Groups|

| Non-profit|

* James Lind Alliance
* Cochrane Collaboration
* Campbell Collaboration
* Science based medicine

|

Governmental|

* Agency for Healthcare Research and Quality (AHRQ)
* EUnetHTA
* Evidence-Informed Policy Network
* German Agency for Quality in Medicine (AEZQ)
* National Institute for Health and Care Excellence (NICE)
* Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)

Academic|

* Centre for Reviews and Dissemination

Other|

* Examine.com

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Health technology assessment. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Engineering:Health_technology_assessment&oldid=4165709"
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template